The 39-year-old from Hull lost his dad from Familial Alzheimer's disease (FAD) when he was a child and knew he had a 50:50 ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

An Australian man who was diagnosed with Alzheimer's at the age of 41 has now been told he doesn't have the disease ...

How well our memory works is determined by a complex combination of things, but we can assess it at home for free ...

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

The annual “Walk to End Alzheimer’s” was one of five scheduled to be held across Mississippi this year. Hub City walkers ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

The headset that began in a hospital lab now sits in the middle of marketing’s biggest debate: how much truth is too much.

The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test, developed by Swiss drugmaker Roche Holding and approved for commercialization by the U.S. Food and Drug ...

A new study reveals that men's brains shrink faster than women's with age, yet women still develop Alzheimer's disease twice ...